4//SEC Filing
Lin Patrick 4
Accession 0000897069-24-001611
CIK 0001533743other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:28 PM ET
Size
17.3 KB
Accession
0000897069-24-001611
Insider Transaction Report
Form 4
Lin Patrick
Chief Business - Strategy Off
Transactions
- Tax Payment
Common Stock
2024-04-05$2.79/sh−539$1,504→ 28,686 total - Tax Payment
Common Stock
2024-07-10$1.71/sh−271$463→ 29,059 total - Award
Restricted Stock Units
2024-06-28+339→ 24,914 totalExercise: $0.00→ Common Stock (339 underlying) - Award
Restricted Stock Units
2024-06-28+339→ 24,575 totalExercise: $0.00→ Common Stock (339 underlying) - Exercise/Conversion
Common Stock
2024-04-05+1,675→ 29,225 total - Exercise/Conversion
Common Stock
2024-07-10+644→ 29,330 total - Award
Restricted Stock Units
2024-06-28+2,713→ 22,201 totalExercise: $0.00→ Common Stock (2,713 underlying) - Award
Restricted Stock Units
2024-06-28+2,035→ 24,236 totalExercise: $0.00→ Common Stock (2,035 underlying)
Footnotes (4)
- [F1]Distribution of vested restricted shares.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001799363
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:28 PM ET
- Size
- 17.3 KB